News

WALL-E is a cute-as-can-be robot with a curious personality whose mission is to help clean up a trash-ridden Earth. Then he ...
The developer Dominium has recently acquired sites in three Phoenix suburbs and plans to create more than 750 affordable ...
Representatives from four Utah entities received the Tonahuac Award from the Federation of United Mexicans in Utah for their ...
Las Vegas(KLAS)-TV Personality, Peter Madrigal, has launched ‘Reality Network’ providing a one stop shop for all things ...
Learn insights from Madrigal Pharmaceuticals' Q2 2025 earnings: Rezdiffra's growth, new patent till 2045, global expansion, and pipeline advances.
WEST CONSHOHOCKEN, Pa. (AP) — WEST CONSHOHOCKEN, Pa. (AP) — Madrigal Pharmaceuticals Inc. (MDGL) on Tuesday reported a loss of $42.3 million in its second quarter. The West Conshohocken, ...
Strong Q1 sales of $137.3M showcase Madrigal Pharmaceuticals, Inc.'s Rezdiffra's growth in non-cirrhotic NASH. Click for my ...
A Mexican national living in Hall County has been sentenced to more than a year in federal prison after he was convicted of ...
Scheana Shay's candid comments about her falling out with Lisa Vanderpump upset one of her former Vanderpump Rules costars ...
Madrigal Pharmaceuticals secures $500 million credit facility to expand its MASH pipeline and refinance existing debt. Quiver AI Summary Madrigal Pharmaceuticals, Inc. has secured a $500 million ...
Madrigal plans to use the funds primarily to advance its pipeline for metabolic dysfunction-associated steatohepatitis (MASH), according to the company’s statement.
Madrigal undertakes no obligation to update any forward-looking statements to reflect new information, events, or circumstances after the date they are made, or to reflect the occurrence of ...